Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengxiang Lv

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cell|January 5, 2021
Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53Peng Jiang, Lejiao Ren, Li Zhi, et al.
Signal Transduction and Targeted Therapy|July 6, 2023
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1Meng Fang, Hong-Kun Wu, Yumeng Pei, et al.
Diabetes|November 30, 2021
MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic DamageHan Feng, Hao Shen, Matthew J Robeson, et al.
Circulation Research|February 14, 2022
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial InflammationYuan Yao, Fan Li, Mao Zhang, et al.
Signal Transduction and Targeted Therapy|June 10, 2025
Mitsugumin 53 drives stem cell differentiation easing intestinal injury and inflammationYumeng Pei, Meng Fang, Hong-Kun Wu, et al.
Nature Medicine|January 5, 2016
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosisTing Zhang, Yan Zhang, Mingyao Cui, et al.
Circulation|June 3, 2010
MG53 constitutes a primary determinant of cardiac ischemic preconditioningChun-Mei Cao, Yan Zhang, Noah Weisleder, et al.
Nature|January 29, 2013
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disordersRuisheng Song, Wei Peng, Yan Zhang, et al.
Nature Metabolism|March 19, 2024
Activation of GPR81 by lactate drives tumour-induced cachexiaXidan Liu, Shijin Li, Qionghua Cui, et al.
Circulation|December 28, 2018
Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic HomeostasisHong-Kun Wu, Yan Zhang, Chun-Mei Cao, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cell|January 5, 2021
Negative regulation of AMPK signaling by high glucose via E3 ubiquitin ligase MG53Peng Jiang, Lejiao Ren, Li Zhi, et al.
Signal Transduction and Targeted Therapy|July 6, 2023
E3 ligase MG53 suppresses tumor growth by degrading cyclin D1Meng Fang, Hong-Kun Wu, Yumeng Pei, et al.
Diabetes|November 30, 2021
MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic DamageHan Feng, Hao Shen, Matthew J Robeson, et al.
Circulation Research|February 14, 2022
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial InflammationYuan Yao, Fan Li, Mao Zhang, et al.
Signal Transduction and Targeted Therapy|June 10, 2025
Mitsugumin 53 drives stem cell differentiation easing intestinal injury and inflammationYumeng Pei, Meng Fang, Hong-Kun Wu, et al.
Nature Medicine|January 5, 2016
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosisTing Zhang, Yan Zhang, Mingyao Cui, et al.
Circulation|June 3, 2010
MG53 constitutes a primary determinant of cardiac ischemic preconditioningChun-Mei Cao, Yan Zhang, Noah Weisleder, et al.
Nature|January 29, 2013
Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disordersRuisheng Song, Wei Peng, Yan Zhang, et al.
Nature Metabolism|March 19, 2024
Activation of GPR81 by lactate drives tumour-induced cachexiaXidan Liu, Shijin Li, Qionghua Cui, et al.
Circulation|December 28, 2018
Glucose-Sensitive Myokine/Cardiokine MG53 Regulates Systemic Insulin Response and Metabolic HomeostasisHong-Kun Wu, Yan Zhang, Chun-Mei Cao, et al.
Pageof 4